Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest

Clinical trial NCT03176186 · NOT_YET_RECRUITING

Trial details

NCT number: NCT03176186
Sponsor: Invero Pharma, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Post-Cardiac Arrest Syndrome

Start date: 2026-03-01
Primary completion: 2029-04-01
Enrollment: 1436

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.